Newsclip®: [Health] CSL gets US approval for flu vaccine | SBS News

"Biopharma company CSL has received US regulatory approval for a formulation of its Flucelvax Quadrivalent influenza vaccine. The formulation is a four-strain, cell culture-derived vaccine, which can also be used for children aged four years and older. It is one of the two formulations of Flucelvax for which phase 3 clinical trials had been under way. CSL acquired pharma giant Novartis' flu vaccine business in 2015 for $US275 million ($A380.65 million) in a deal that included the North Carolina vaccine plant, where Flucelvax will be manufactured.",

0 comments | 1 clip



Last clipped by

Hey! Thanks for checking out Newsclip®!

Click on this Trending Newsclip® Stack to read other top media reports on this topic.

Be sure to clip to your personal newspaper, like, comment and share!

Newsclip® is the leader of Social News Discovery®.

Welcome to the Newsclip® beta release!

Please enjoy the site during our beta phase and provide us with feedback on suggestions and issue details. Please remember that we are still in beta and there will be issues and site changes during this time.

Newsclip® the leading Online Social Newspaper, find trending articles through Social News Discovery®!

Invite Friends to Newsclip®

Invite your Facebook friends to follow you!

You can reopen the "Getting Started Tutorial" dialog from within the About menu in the top right corner.